Akt3 Deficiency in Macrophages Promotes Foam Cell Formation and Atherosclerosis in Mice

被引:86
作者
Ding, Liang [1 ]
Biswas, Sudipta [1 ]
Morton, Richard E. [2 ]
Smith, Jonathan D. [2 ]
Hay, Nissim [3 ]
Byzova, Tatiana V. [1 ]
Febbraio, Maria [1 ]
Podrez, Eugene A. [1 ]
机构
[1] Cleveland Clin, Dept Mol Cardiol, Lerner Res Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA
[3] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA
基金
美国国家卫生研究院;
关键词
KINASE-B-GAMMA; ACYL-COA; CHOLESTEROL ACYLTRANSFERASE-2; SCAVENGER RECEPTOR; EXPRESSION; PROTEIN; LIPOPROTEINS; DOWNSTREAM; INHIBITOR; MEMBRANE;
D O I
10.1016/j.cmet.2012.04.020
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Akt, a serine-threonine protein kinase, exists as three isoforms. The Akt signaling pathway controls multiple cellular functions in the cardiovascular system, and the atheroprotective endothelial cell-dependent role of Akt1 has been recently demonstrated. The role of Akt3 isoform in cardiovascular pathophysiology is not known. We explored the role of Akt3 in atherosclerosis using mice with a genetic ablation of the Akt3 gene. Using hyperlipidemic ApoE(-/-) mice, we demonstrated a macrophage-dependent, atheroprotective role for Akt3. In vitro experiments demonstrated differential subcellular localization of Akt1 and Akt3 in macrophages and showed that Akt3 specifically inhibits macrophage cholesteryl ester accumulation and foam cell formation, a critical early event in atherogenesis. Mechanistically, Akt3 suppresses foam cell formation by reducing lipoprotein uptake and promoting ACAT-1 degradation via the ubiquitin-proteasome pathway. These studies demonstrate the nonredundant atheroprotective role for Akt3 exerted via the previously unknown link between the Akt signaling pathway and cholesterol metabolism.
引用
收藏
页码:861 / 872
页数:12
相关论文
共 32 条
[1]  
Baglione Julie, 2006, V129, P83
[2]   Acyl-coenzyme A: cholesterol acyltransferases [J].
Chang, Ta-Yuan ;
Li, Bo-Liang ;
Chang, Catherine C. Y. ;
Urano, Yasuomi .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 297 (01) :E1-E9
[3]   Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo [J].
Chen, JH ;
Somanath, PR ;
Razorenova, O ;
Chen, WS ;
Hay, N ;
Bornstein, P ;
Byzova, TV .
NATURE MEDICINE, 2005, 11 (11) :1188-1196
[4]   Leptin Deficiency and Beta-Cell Dysfunction Underlie Type 2 Diabetes in Compound Akt Knockout Mice [J].
Chen, William S. ;
Peng, Xiao-Ding ;
Wang, Yong ;
Xu, Pei-Zhang ;
Chen, Mei-Ling ;
Luo, Yongmei ;
Jeon, Sang-Min ;
Coleman, Kevin ;
Haschek, Wanda M. ;
Bass, Joseph ;
Philipson, Louis H. ;
Hay, Nissim .
MOLECULAR AND CELLULAR BIOLOGY, 2009, 29 (11) :3151-3162
[5]   Identification of the interaction site within acyl-CoA: Cholesterol acyltransferase 2 for the isoform-specific inhibitor pyripyropene A [J].
Das, Akash ;
Davis, Matthew A. ;
Tomoda, Hiroshi ;
Omura, Satoshi ;
Rudel, Lawrence L. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (16) :10453-10460
[6]   A novel AKT3 mutation in melanoma tumours and cell lines [J].
Davies, M. A. ;
Stemke-Hale, K. ;
Tellez, C. ;
Calderone, T. L. ;
Deng, W. ;
Prieto, V. G. ;
Lazar, A. J. F. ;
Gershenwald, J. E. ;
Mills, G. B. .
BRITISH JOURNAL OF CANCER, 2008, 99 (08) :1265-1268
[7]   Activation of a Metabolic Gene Regulatory Network Downstream of mTOR Complex 1 [J].
Duevel, Katrin ;
Yecies, Jessica L. ;
Menon, Suchithra ;
Raman, Pichai ;
Lipovsky, Alex I. ;
Souza, Amanda L. ;
Triantafellow, Ellen ;
Ma, Qicheng ;
Gorski, Regina ;
Cleaver, Stephen ;
Heiden, Matthew G. Vander ;
MacKeigan, Jeffrey P. ;
Finan, Peter M. ;
Clish, Clary B. ;
Murphy, Leon O. ;
Manning, Brendan D. .
MOLECULAR CELL, 2010, 39 (02) :171-183
[8]   Role for Akt3/Protein kinase Bγ in attainment of normal brain size [J].
Easton, RM ;
Cho, H ;
Roovers, K ;
Shineman, DW ;
Mizrahi, M ;
Forman, MS ;
Lee, VMY ;
Szabolcs, M ;
de Jong, R ;
Oltersdorf, T ;
Ludwig, T ;
Efstratiadis, A ;
Birnbaum, MJ .
MOLECULAR AND CELLULAR BIOLOGY, 2005, 25 (05) :1869-1878
[9]   Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice [J].
Febbraio, M ;
Podrez, EA ;
Smith, JD ;
Hajjar, DP ;
Hazen, SL ;
Hoff, HF ;
Sharma, K ;
Silverstein, RL .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (08) :1049-1056
[10]   Loss of Akt1 leads to severe atherosclerosis and occlusive coronary artery disease [J].
Fernández-Hernando, Carlos ;
Ackah, Eric ;
Yu, Jun ;
Suarez, Yajaira ;
Murata, Takahisa ;
Iwakiri, Yasuko ;
Prendergast, Jay ;
Miao, Robert Q. ;
Birnbaum, Morris J. ;
Sessa, William C. .
CELL METABOLISM, 2007, 6 (06) :446-457